000 01313 a2200361 4500
005 20250515150541.0
264 0 _c20081218
008 200812s 0 0 eng d
022 _a1526-632X
024 7 _a10.1212/01.wnl.0000335938.26633.e7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBönnemann, Carsten G
245 0 0 _aLinking SMN to SMA: an assay for the rescuer.
_h[electronic resource]
260 _bNeurology
_cNov 2008
300 _a1752-3 p.
_bdigital
500 _aPublication Type: Comment; Editorial
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aCentral Nervous System Agents
_xtherapeutic use
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aHumans
650 0 4 _aHydroxyurea
_xtherapeutic use
650 0 4 _aMotor Neurons
_xdrug effects
650 0 4 _aMuscular Atrophy, Spinal
_xblood
650 0 4 _aPhenylbutyrates
_xtherapeutic use
650 0 4 _aProtein Splicing
_xgenetics
650 0 4 _aResearch Support as Topic
650 0 4 _aSurvival of Motor Neuron 1 Protein
_xblood
650 0 4 _aTranscription, Genetic
650 0 4 _aValproic Acid
_xtherapeutic use
700 1 _aFinkel, Richard S
773 0 _tNeurology
_gvol. 71
_gno. 22
_gp. 1752-3
856 4 0 _uhttps://doi.org/10.1212/01.wnl.0000335938.26633.e7
_zAvailable from publisher's website
999 _c18485661
_d18485661